- Home
- KIDS vs CRMD Comparison
KIDS vs CRMD Comparison
Compare KIDS & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIDS
- CRMD
- Stock Information
- Founded
- KIDS 2007
- CRMD 2006
- Country
- KIDS United States
- CRMD United States
- Employees
- KIDS N/A
- CRMD N/A
- Industry
- KIDS Medical/Dental Instruments
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- KIDS Health Care
- CRMD Health Care
- Exchange
- KIDS Nasdaq
- CRMD Nasdaq
- Market Cap
- KIDS 524.3M
- CRMD 925.6M
- IPO Year
- KIDS 2017
- CRMD 2010
- Fundamental
- Price
- KIDS $19.25
- CRMD $11.12
- Analyst Decision
- KIDS Strong Buy
- CRMD Strong Buy
- Analyst Count
- KIDS 7
- CRMD 8
- Target Price
- KIDS $34.14
- CRMD $17.57
- AVG Volume (30 Days)
- KIDS 131.8K
- CRMD 4.6M
- Earning Date
- KIDS 11-05-2025
- CRMD 10-29-2025
- Dividend Yield
- KIDS N/A
- CRMD N/A
- EPS Growth
- KIDS N/A
- CRMD N/A
- EPS
- KIDS N/A
- CRMD 0.79
- Revenue
- KIDS $220,733,000.00
- CRMD $121,484,498.00
- Revenue This Year
- KIDS $19.26
- CRMD $404.81
- Revenue Next Year
- KIDS $17.15
- CRMD $56.11
- P/E Ratio
- KIDS N/A
- CRMD $14.00
- Revenue Growth
- KIDS 26.08
- CRMD 14970.29
- 52 Week Low
- KIDS $16.59
- CRMD $5.60
- 52 Week High
- KIDS $32.30
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- KIDS 41.26
- CRMD 34.64
- Support Level
- KIDS $19.30
- CRMD $12.73
- Resistance Level
- KIDS $21.35
- CRMD $13.83
- Average True Range (ATR)
- KIDS 0.81
- CRMD 0.81
- MACD
- KIDS -0.13
- CRMD -0.30
- Stochastic Oscillator
- KIDS 7.39
- CRMD 0.90
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.